"Regeneron is proud to recognize the top 40 Regeneron Science Talent Search finalists. These talented young scientists are already exploring life-changing solutions for the world's problems and are poised to lead innovation for future generations," said George D. Yancopoulos, M.D., Ph.D., President and Chief Scientific Officer of Regeneron. "I've had the opportunity to meet many of my fellow Science Talent Search alumni who have gone on to become notable scientists and entrepreneurs, underscoring the critical role the program can play in launching a prominent scientific career."
"These 40 young scientists, engineers and mathematicians are poised to be the next generation of leaders in business and academia," said Maya Ajmera, president and CEO of Society for Science & the Public and publisher of Science News. "Science breeds curiosity, enabling innovators to develop solutions that will help solve our world's most pressing challenges. We are proud to celebrate 75 years of recognizing new innovations and research demonstrating the outstanding capabilities of young minds." The Society for Science & the Public has produced and organized the Science Talent Search since it was founded in 1942.
Regeneron Science Talent Search 2017 Fast Facts
- The Regeneron Science Talent Search 2017 finalists are from 34 schools in 17 states. Sixty-two percent of this year's finalists are male, while 38 percent are female.
- Forty finalists were selected from roughly 300 scholars and more than 1,700 entrants based on the originality and creativity of their scientific research, as well as their achievement and leadership both inside and outside of the classroom.
- Finalist projects cover multiple disciplines of science, including behavioral and social science, biochemistry, cellular and molecular biology, chemistry, computer science, computational biology and bioinformatics, earth and planetary science, engineering, environmental science, mathematics, medicine and health, materials science, physics, and space science.
- Finalists' research projects include a machine learning tool to detect small cell lung cancer; a computational model demonstrating the effect of carbon tax policies on the global agricultural economy; and a high-performance biodegradable battery for transient electronics.
- For a list of this year's finalists, visit https://student.societyforscience.org/regeneronsts-finalists-2017.
About the Regeneron Science Talent Search
The Regeneron Science Talent Search, a program of Society for Science & the Public since 1942, is the nation's oldest and most prestigious science and math competition for high school seniors. Each year, approximately 1,700 student entrants to the Science Talent Search submit original research in critically important scientific fields of study and are judged by leading experts in their fields. Unique among high school competitions in the U.S. and globally, the Regeneron Science Talent Search focuses on identifying the next generation of scientists and engineers who will provide critical leadership in solving some of the world's most pressing challenges while shaping the future of research and development for our nation and the world.
As part of its 10-year, $100 million commitment, Regeneron has significantly increased awards to better reward the best and brightest young talent and encourage their continued pursuit of scientific innovation. Regeneron has nearly doubled the overall award distribution to $3.1 million annually, increased the top award to $250,000.
Program alumni include recipients of the world's most coveted science and math honors, including eleven National Medals of Science, four Breakthrough Prizes, eighteen MacArthur Foundation Fellowships, two Fields Medals and twelve Nobel Prizes. Distinguished Science Talent Search alumni include Society Trustees Mary Sue Coleman (president emeritus, University of Michigan), Tom Leighton (co-founder and CEO, Akamai Technologies), Paul Maddon (founder of Progenics) and Frank Wilczek (2004 Nobel Prize in Physics), among many others.
Intel was the title sponsor of the Science Talent Search from 1998-2016. For the first 55 years (1942-1997) of the Science Talent Search, Westinghouse was the title sponsor.
Learn more at https://student.societyforscience.org/regeneron-sts and https://medium.com/regeneron-science-talent-search.
About Society for Science & the Public
Society for Science & the Public is dedicated to the achievement of young scientists in independent research and to public engagement in science. Established in 1921, Society is a nonprofit whose vision is to promote the understanding and appreciation of science and the vital role it plays in human advancement. Through its world-class competitions, including the Regeneron Science Talent Search, the Intel International Science and Engineering Fair, and the Broadcom MASTERS, and its award-winning magazine, Science News and Science News for Students, Society for Science & the Public is committed to inform, educate, and inspire. Learn more at www.societyforscience.org and follow us on Facebook, Twitter, Instagram and Snapchat (Society4Science).
About Regeneron Pharmaceuticals, Inc.
Regeneron (NASDAQ: REGN) is a leading science-based biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions. Regeneron commercializes medicines for eye diseases, high LDL cholesterol and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including rheumatoid arthritis, atopic dermatitis, asthma, pain, cancer and infectious diseases. For additional information about the company, please visit www.regeneron.com or follow @Regeneron on Twitter.
Media Contact at Society for Science & the Public
Media Contact at Regeneron
Media Contact at North of Nine Communications
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/forty-of-nations-brightest-young-scientists-named-regeneron-science-talent-search-2017-finalists-300395479.html
SOURCE Regeneron Pharmaceuticals, Inc.